Bone Marrow Transplant Performance Results
|
Monitoring our care helps us evaluate and improve the way we deliver care. We emphasize areas where experts agree on the best treatment for a certain condition. (For more detail, click on each underlined measure below. A dash " - " means that there is no available comparison.) |
DHMC 2006-2007 | Top 10% | Average |
|---|---|---|---|
| OUTPATIENT TREATMENT | |||
| Outpatient bone marrow transplant: Percent of patients having some or all of their autologous bone marrow transplant done as an outpatient. | 19% | - | - |
| HOSPITAL STAY | |||
| Average length of hospital stay: The average total number of days that patients stay at the hospital for their autologous transplant. |
21 Days |
- |
20 Days |
| Time for the transplant to take hold: The average number of days until engraftment (the time until the transplant takes hold) for autologous transplants. |
12 Days |
- | - |
| Nausea: Percent of patients who experience significant nausea during hospitalization for autologous transplant. | 26% | - | - |
| Vomiting: Percent of patients who vomit frequently during hospitalization for autologous transplant. | 3% | - | - |
| Mouth tissue irritation: Percent of patients with painful irritation of mouth tissue during hospitalization for autologous transplant. | 27% | - | - |
| OUTCOMES | |||
| Multiple myeloma - 100 day survival: Percent of multiple myeloma patients living 100 or more days following their autologous transplant procedure. | 100% | - | - |
| Multiple myeloma - 1 year survival: Percent of multiple myeloma patients living one or more years following their autologous transplant procedure. | 93% | - | - |
| Multiple myeloma - 2 year survival: Percent of multiple myeloma patients living two or more years following their autologous transplant procedure. | 75% | - | - |
| Leukemia - 100 day survival: Percent of acute myelogenous leukemia (AML) patients living 100 or more days following their autologous transplant procedure. | 90% | - | - |
| Leukemia - 1 year survival: Percent of acute myelogenous leukemia (AML) patients living one or more years following their autologous transplant procedure. | 57% | - | - |
| Leukemia - 2 year survival: Percent of acute myelogenous leukemia (AML) patients living two or more years following their autologous transplant procedure. | 51% | - | - |
| Lymphoma - 100 day survival: Percent of lymphoma patients living 100 or more days following their autologous transplant procedure, including patients with Hodgkin's Disease as well as all grades of non-Hodgkin's lymphoma. | 90% | - | - |
| Lymphoma - 1 year survival: Percent of lymphoma patients living one or more years following their autologous transplant procedure, including patients with Hodgkin's Disease as well as all grades of non-Hodgkin's lymphoma. | 73% | - | - |
| Lymphoma - 2 year survival: Percent of lymphoma patients living two or more years following their autologous transplant procedure, including patients with Hodgkin's Disease as well as all grades of non-Hodgkin's lymphoma. | 58% | - | - |
| Lymphoma - 3 year survival: Percent of lymphoma patients living three or more years following their autologous transplant procedure, including patients with Hodgkin's Disease as well as all grades of non-Hodgkin's lymphoma. | 55% | - | - |
|
We ask our patients to rate our care as one way to evaluate and improve our services. (For more detail, click on each underlined measure below. A dash " - " means that there is no available comparison.) |
DHMC 2005-2007 | Top 10% | Average |
|---|---|---|---|
| HOSPITAL STAY | |||
| Overall satisfaction: BMT patients rated all aspects of their hospital stay using a scale of Very Good (100) to Very Poor (0). |
85 |
- | - |
| Doctor care: BMT patients rated the doctors who cared for them during their hospital stay using a scale of Very Good (100) to Very Poor (0). |
88 |
- | - |
| Nursing care: BMT patients rated the nurses who cared for them during their hospital stay using a scale of Very Good (100) to Very Poor (0). |
91 |
- | - |
| Visitor and family services: BMT patients rated services for visitors and family at the hospital using a scale of Very Good (100) to Very Poor (0). |
86 |
- | - |
| Emotional support: BMT patients rated how well their emotional and spiritual needs were met during their hospital stay using a scale of Very Good (100) to Very Poor (0). |
85 |
- | - |
| Pain management: BMT patients rated how well their pain was controlled during their hospital stay using a scale of Very Good (100) to Very Poor (0). |
89 |
- | - |
| Involved in decisions: BMT patients rated the effort of staff to involve them in decisions about their treatment using a scale of Very Good (100) to Very Poor (0). |
83 |
- | - |
| Overall care: BMT patients rated the overall care they received during their hospital stay using a scale of Very Good (100) to Very Poor (0). |
94 |
- | - |
| APPOINTMENT WITH DOCTOR | |||
| Overall satisfaction: BMT patients rated their overall satisfaction with a visit to their doctor using a scale of Excellent (100) to Poor (0). |
89 |
- | - |
| Ease of making appointment: BMT patients rated the ease of making an appointment with their doctor using a scale of Excellent (100) to Poor (0). |
86 |
- | - |
| Doctors' clinical skills: BMT patients rated the clinical skills of their doctor using a scale of Excellent (100) to Poor (0). |
93 |
- | - |
| Doctors' thoroughness: BMT patients rated the thoroughness of their doctor using a scale of Excellent (100) to Poor (0). |
93 |
- | - |
| Involved in decisions: BMT patients rated how well they were involved in their medical decisions using a scale of Excellent (100) to Poor (0). |
90 |
- | - |
| Nurses' caring/concern: BMT patients rated the caring and concern shown by nursing staff during a visit to their doctor using a scale of Excellent (100) to Poor (0). |
91 |
- | - |
| Staff sensitivity: BMT patients rated the sensitivity of all staff to their personal needs during a visit to their doctor using a scale of Excellent (100) to Poor (0). |
90 |
- | - |
Where to go for more information
- Bone Marrow Transplant Program at the Norris Cotton Cancer Center
- A Typical Patient's Journey: Bone Marrow Transplantation (BMT)
- Center for Shared Decision Making
- Things you can do to make your health care safe
We are interested in your feedback and questions. Please send email to: QualityReports@hitchcock.org to let us know if this is helpful, or if you need something you can't find here.
